Page last updated: 2024-09-05

sb 203580 and nsc 664704

sb 203580 has been researched along with nsc 664704 in 5 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(nsc 664704)
Trials
(nsc 664704)
Recent Studies (post-2010) (nsc 664704)
3,48941,13795050

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)nsc 664704 (IC50)
nuclear receptor subfamily 0 group B member 1Homo sapiens (human)0.8335
Cyclin-T1Homo sapiens (human)0.064
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.4
Tyrosine-protein kinase LckHomo sapiens (human)0.47
Cyclin-dependent kinase 1Homo sapiens (human)0.4
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 21.5
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.4
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)0.4243
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.064
Glycogen synthase kinase-3 betaRattus norvegicus (Norway rat)0.4243
Cyclin-A2Homo sapiens (human)0.73
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.064
Cyclin-dependent kinase 2Homo sapiens (human)0.73
Mitogen-activated protein kinase 1Homo sapiens (human)9
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.064
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.023
Glycogen synthase kinase-3 betaHomo sapiens (human)0.0657
Cyclin-dependent kinase 9Homo sapiens (human)0.064
Cyclin-A1Homo sapiens (human)0.73
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.6314
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.6314
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.4
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)0.4243

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1
Laufer, S; Pillaiyar, T1

Reviews

1 review(s) available for sb 203580 and nsc 664704

ArticleYear
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Protein Kinase Inhibitors; SARS-CoV-2; Signal Transduction; Virus Replication

2022

Other Studies

4 other study(ies) available for sb 203580 and nsc 664704

ArticleYear
The selectivity of protein kinase inhibitors: a further update.
    The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3

    Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera

2007
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013